{"id":9109,"date":"2020-05-04T16:35:33","date_gmt":"2020-05-04T15:35:33","guid":{"rendered":"https:\/\/m3globalresearch.blog\/?p=9109"},"modified":"2020-05-04T16:35:33","modified_gmt":"2020-05-04T15:35:33","slug":"covid-19-testing","status":"publish","type":"post","link":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/","title":{"rendered":"“Covid-19 Testing” in collaboration with the University of Birmingham","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\"This collaboration between M3 and the University of Birmingham provides an unprecedented global insight into the opinions of health care professionals regarding the emerging diagnostic landscape for COVID-19. \n\n\nThis project explores preference for different diagnostic test options and how these might be deployed in local clinical practice. The pipeline of antigen and antibody tests is evolving rapidly and the perspective of health care professionals is essential to guiding this development\"\n<\/div>\n\t\t\t\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t
Dr.Alex Richter<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
University of Birmingham, April 2020<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Overview<\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

This research study investigated how 20,996 health care professionals (HCP), in 29 countries, might use SARS-CoV-2 antigen and antibody tests in COVID-19 cases. We explore questions around choice of test, type of test, when they should be used, and mode of delivery, as well as preferences about sensitivity and specificity, to inform the development of new tests.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Methodology<\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

A 10-minute online quantitative survey was conducted with a random sample of HCPs. Recruitment was via email to members of M3 Global Research\u2019s proprietary panel, and partner panels Ekas, Eksen, Fine, m360 Research, M3 India, M3 Inc., Medi:Gate, Medlive, Soda, and Top Of Mind. The sponsor was not named at any point in the research, and there was no incentive for taking part. Fieldwork for this study was conducted between 16-23 April 2020, on the Confirmit platform. Data were analysed based on all respondents, at country level, and comparing responses from primary care, and secondary care physicians.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

20,996 healthcare professionals working across a broad range of specialties in North and South America, Europe, Africa, Asia, and Australasia participated in the study. The sample included 2,628 doctors working in primary care, 11,412 secondary care physicians, 1,452 clinical healthcare workers, 1,519 nurses, 1,172 pharmacists, and 2,813 \u2018other\u2019<\/strong> HCPs.<\/b><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Choice of Test<\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Overall, 63% of HCP respondents are confident that they know which test should be used during which stage of the illness. This increases to 67% in primary care physicians.<\/p>

At a country level confidence is highest in Argentina (81%), China (81%), India (87%), and South Africa (93%). Japan stands out in terms of low confidence in decision making on testing, with 78% of respondents unsure which test should be used, and when.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Stage of Illness <\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Respondents are generally more confident about the relative accuracy of antigen tests and the stage of illness they should be used in. With antibody testing there is less clarity on whether a test should be used during the recovery phase (23%), or one-month post-recovery (67%).<\/p>

At a country level, Indian and South African respondents are most likely to use an antigen test earlier, with 32% of South African HCPs, and 28% of Indian HCPs, agreeing that the test would be most accurate before symptoms are present.<\/p>

Responses for the antibody test are less polarised, but again Indian and South African HCPs would use tests earlier.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Importance of Tests<\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

When asked how important the antibody and antigen tests are in controlling the pandemic, support for the antigen test is much more pronounced. 91% believe an antigen test is critically or very important, compared to 79% for an antibody test.<\/p>

There is very little divergence when comparing secondary and primary care respondents, although GPs (75% choosing \u2018critically important\u2019 or \u2018very important\u2019) are less supportive of an antibody test than secondary care physicians (78%).<\/p>

At a country level the antigen test is seen as most important to HCPs in Australia, China, New Zealand, and Poland. By contrast, the antibody test is seen as critically important by 60% French respondents, and 59% US respondents.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Specificity or Sensitivity?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Overall, most HCPs would prefer antigen tests with both high sensitivity and high specificity, with very little variation between the primary and secondary care respondents.For the antibody tests there is a clear preference for sensitivity over specificity, requiring tests to specifically include those who have already had COVID-19.<\/p>

For antigen tests there is a slight preference for specificity over sensitivity (i.e. a test optimised to correctly exclude people from having had COVID-19).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Likelihood of Test Usage<\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Respondents expect to be more likely to use the antigen test than the antibody test, with very little difference between primary care and secondary care physicians, with the former slightly more likely to use antibody testing.<\/p>

Overall though, taking all \u2018positive\u2019 statements (i.e. top three), 80% of respondents think they are likely to use antigen tests, and 78% are likely to use antibody tests in their clinical practice.<\/p>

At a country level, likelihood of using the antibody test is at its lowest in Australia where 32% don\u2019t expect to use the tests, Argentina (30%), Germany (29%), Austria (30%), and South Korea (30%).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Home or Lab Testing?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Across all respondents there is a slight preference for laboratory testing (52%) rather than home testing (48%), increasing slightly to 53% in primary care respondents.<\/p>

This question sees the most divergence at a country level, reflecting different cultures, healthcare systems and expectations. In Finland, for example, 90% respondents would want laboratory testing. By contrast in the UK and Poland, 63% prefer home testing.<\/p>

Other strong support for laboratory testing emerges from China (63%), Belgium (66%), South Korea (67%), Sweden (73%), and Turkey (69%).At a country level, likelihood of using the antibody test is at its lowest in Australia where 32% don\u2019t expect to use the tests, Argentina (30%), Germany (29%), Austria (30%), and South Korea (30%)<\/p>

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Type of Test <\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Overall there is a preference for saliva tests to detect COVID-19, with small variations between primary and secondary care. Primary care respondents are slightly less supportive of a saliva test (42% vs 45% in primary care physicians).<\/p>

Again, there are significant regional variations. A finger prick test is the preferred option in France (54%),and Switzerland (56%). Some countries demonstrate particularly high support for a saliva test, including Argentina (66%), Canada (56%), Mexico (53%), and the USA (56%).<\/p>

In the UK support for a saliva test and a finger prick test is fairly evenly split, with 45% favouring a finger prick test over a saliva test (43%).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Impact of Testing<\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

HCPs have a unique view point as they are not only clinicians, but they and their families are all at risk of COVID-19 and many have already been affected.<\/p>

There is concern around what is known about the prevalence and duration of effective immunity post natural infection, and the impact that testing can have in light of this.<\/p>

Some respondents challenged whether there should be any impact on an individual as immunity cannot be assumed, particularly for the antigen test. There was concern about asymptomatic shedding and ongoing transmission of the illness which still requires PPE and social distancing.<\/p>

Benefits of a positive antibody test were clearer, although the absence of assumed immunity means PPE, social distancing and hand washing remain major considerations.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Accuracy of Tests<\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Only 14% of HCPs overall responded negatively about the accuracy of the tests currently available to them, with very little deviation between the primary and secondary care groups.<\/p>

Countries most concerned about the accuracy of their tests, with higher percentages of HCPs answering \u2018not at all\u2019 or \u2018not very\u2019 confident, were Japan (28%), Russia (20%), Sweden (21%), and the UK (25%).<\/p>

At the other end of the scale, HCPs in China, India, Mexico, and South Africa are most confident in the accuracy of tests available to them at the moment.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Conclusions<\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

COVID-19 has presented an urgent need for novel diagnostic assays to establish the presence of, and exposure to, the virus. Understanding perceptions and confidence in testing enables a new phase of test development that is tailored to the needs of individuals and governments to address this pandemic.<\/p>

It is evident that the global picture is not convergent; this is particularly apparent when we look at preferences in terms of the type of tests, and how they\u2019re delivered, but also what is currently available and perceived accuracy.<\/p>

For confidence in the accuracy of tests they must be used at the correct point in the disease cycle, and this will require physician education to counter balance the current lack of confidence.<\/p>

The priority for HCPs is an effective antigen test to meet the needs of physicians and patients in markets that don\u2019t currently have adequate provision in place. The identified need for a sensitive antibody test is also clear, and respondents expect to be using them in their clinical practice in the future. There is however an urgent need to relate antibody levels to loss of infectivity to others, and efficacy and duration of immunity against subsequent infection.<\/p>

Responses indicate that testing would provide confidence for HCPs in returning to work and their interactions with family and friends, however hygiene and social distancing behaviours are less influenced. The impact of testing informs broader benefits to the economy and safer relaxation of lockdown restrictions.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n

Do you want to take part in paid research surveys?<\/h2>

Join\u00a0 M3 Global Research to share your professional experience and take part in surveys on health related topics<\/p>Register<\/a>\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"excerpt":{"rendered":"

“This collaboration between M3 and the University of Birmingham provides an unprecedented global insight into the opinions of health care professionals regarding the emerging diagnostic landscape for COVID-19. This project explores preference for different diagnostic test options and how these might be deployed in local clinical practice. The pipeline of antigen and antibody tests is […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":1,"featured_media":9149,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_eb_attr":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3534],"tags":[6706,6707,6708,245,249,250,256,6709,6693,6661,6694,6662,6663,6664,6695,6696,6665,6668,6704,2050,1718,1719,6705,6710,6711,2730,6712,6713,6714,6715,6716,6717,6718,296,302,238,239,240,241,242,243,6697,3941,3945,3946,3947,3949,6719,354,381,385,386,387,388,389,6720,6721,409,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,430,431,432,433,434,435,436,437,438,439,440,441,442,443,444,445,446,447,448,449,6722,6723,480,6680,6681,2212,3969,3970,4522,4523,4524,2192,3968,6682,4525,4526,4521,6724,516,517,518,519,1809,533,540,3566,543,542,548,558,6698,204],"class_list":["post-9109","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-inside-m3-insights","tag-antibody","tag-antigen-test","tag-anton-richter","tag-betald-marknadsundersokning","tag-betalt-markedsundersogelse","tag-betalt-markedsundersokelse","tag-bezahlte-marktforschung","tag-birmingham","tag-corona-threat-level","tag-coronaviridae","tag-coronavirus-and-sars","tag-coronavirus-cause","tag-coronavirus-hku1","tag-coronavirus-in-dogs","tag-coronavirus-in-europe","tag-coronavirus-in-us","tag-coronavirus-infection","tag-coronavirus-symptoms-in-humans","tag-coronavirus-tracker-study","tag-coronavirus-update","tag-covid","tag-covid-19","tag-covid-19-and-media","tag-covid-19-antibody","tag-covid-19-antigen","tag-covid-19-news","tag-diagnostic-test","tag-dr-adrian-shields","tag-dr-alex-richter","tag-dr-alex-richter-birmingham","tag-dr-alex-richter-university-of-birmingham","tag-ekas","tag-eksen","tag-empresas-de-investigacion-de-mercado","tag-encuestas-de-investigacion-de-mercado","tag-etude-de-marche","tag-etude-de-marche-de-la-sante","tag-etude-de-marche-pour-les-medecins-ricerche-di-mercato-per-medici","tag-etude-de-marche-pour-les-patients","tag-etudes-de-marche","tag-etudes-de-marche-remunerees","tag-europe-and-the-usa","tag-globaali-influenssapandemia","tag-global-influensapandemi","tag-global-influenza-pandemic","tag-global-influenzapandemi","tag-globale-influenzapandemie","tag-hannah-brown","tag-healthcare-market-research","tag-industria-de-investigacion-de-mercado","tag-investigacion-de-mercado","tag-investigacion-de-mercado-para-medicos","tag-investigacion-de-mercado-para-pacientes","tag-investigacion-de-mercado-remunerada","tag-investigacion-de-mercado-sanitario","tag-m3-inc","tag-m3-india","tag-maksettu-markkinatutkimus","tag-markedsforingsundersogelser-markkinointitutkimusyritykset","tag-markedsforingsundersokelser","tag-markedsundersogelse","tag-markedsundersogelse-inden-for-sundhedsydelser","tag-markedsundersogelser","tag-markedsundersogelser-for-laeger","tag-markedsundersogelser-for-patienter","tag-markedsundersogelsesindustri","tag-markedsundersokelser","tag-markedsundersokelser-for-leger","tag-markedsundersokelser-for-pasienter","tag-markedsundersokelser-innen-helsevesenet","tag-markedsundersokelsesindustri","tag-market-research","tag-market-research-for-patients","tag-market-research-for-physicians-marktforschung-fur-arzte","tag-market-research-industry","tag-marketing-research-companies","tag-marketing-research-surveys","tag-markkinatutkimus","tag-markkinatutkimus-laakareille","tag-markkinatutkimus-potilaille","tag-markkinatutkimusala","tag-markkinointitutkimukset","tag-marknadsforingsforetag","tag-marknadsundersokning","tag-marknadsundersokningar","tag-marknadsundersokningar-for-lakare","tag-marknadsundersokningar-for-patienter","tag-marknadsundersokningar-inom-sjukvarden","tag-marknadsundersokningsindustri","tag-marktforschung","tag-marktforschung-fur-patienten","tag-marktforschung-im-gesundheitswesen","tag-marktforschungsbranche","tag-marktforschungsumfragen","tag-marktforschungsunternehmen","tag-medigate","tag-neil-phillips","tag-paid-market-research","tag-pandeeminen","tag-pandemi","tag-pandemia","tag-pandemia-influenzale-globale","tag-pandemia-mundial-de-gripe","tag-pandemias","tag-pandemiat","tag-pandemics","tag-pandemie","tag-pandemie-mondiale-de-grippe","tag-pandemie-pandemia","tag-pandemien","tag-pandemier","tag-pandemies","tag-professor-drayson-birmingham","tag-ricerca-di-mercato","tag-ricerche-di-mercato-a-pagamento","tag-ricerche-di-mercato-nel-settore-sanitario","tag-ricerche-di-mercato-per-pazienti","tag-sars-cov-2","tag-secteur-des-etudes-de-marche","tag-settore-delle-ricerche-di-mercato","tag-si","tag-societa-di-ricerche-di-mercato","tag-societes-detudes-de-marche","tag-sondaggi-di-ricerca-di-mercato","tag-terveydenhuollon-markkinatutkimus","tag-threat-level","tag-university-of-birmingham"],"acf":[],"yoast_head":"\n"Covid-19 Testing" in collaboration with the University of Birmingham – M3 Global Research<\/title>\n<meta name=\"description\" content=\"This research study investigated how 20,996 healthcare professionals, in 29 countries, might use SARS-CoV-2 antigen and antibody tests in COVID-19 cases.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\""Covid-19 Testing" in collaboration with the University of Birmingham\" \/>\n<meta property=\"og:description\" content=\"This research study investigated how 20,996 healthcare professionals, in 29 countries, might use SARS-CoV-2 antigen and antibody tests in COVID-19 cases.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/\" \/>\n<meta property=\"og:site_name\" content=\"M3 Global Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/en-gb.facebook.com\/M3GlobalResearch\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-04T15:35:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/05\/Slide1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"m3gr-blog-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@M3GR_Community\" \/>\n<meta name=\"twitter:site\" content=\"@M3GR_Community\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"m3gr-blog-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"13 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/\"},\"author\":{\"name\":\"m3gr-blog-admin\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/person\\\/11bace963d7a45380011c4911a822a6c\"},\"headline\":\"“Covid-19 Testing” in collaboration with the University of Birmingham\",\"datePublished\":\"2020-05-04T15:35:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/\"},\"wordCount\":1436,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/Slide1.jpeg\",\"keywords\":[\"antibody\",\"antigen test\",\"anton richter\",\"betald marknadsunders\u00f6kning\",\"betalt markedsunders\u00f8gelse\",\"betalt markedsunders\u00f8kelse\",\"bezahlte Marktforschung\",\"birmingham\",\"corona threat level\",\"Coronaviridae\",\"coronavirus and sars\",\"coronavirus cause\",\"coronavirus hku1\",\"coronavirus in dogs\",\"coronavirus in europe\",\"coronavirus in us\",\"coronavirus infection\",\"coronavirus symptoms in humans\",\"Coronavirus tracker study\",\"coronavirus update\",\"COVID\",\"COVID-19\",\"COVID-19 and media\",\"covid-19 antibody\",\"covid-19 antigen\",\"COVID-19 news\",\"diagnostic test\",\"Dr. Adrian Shields\",\"Dr.Alex Richter\",\"Dr.Alex Richter Birmingham\",\"Dr.Alex Richter University of Birmingham\",\"ekas\",\"eksen\",\"empresas de investigaci\u00f3n de mercado\",\"encuestas de investigaci\u00f3n de mercado\",\"\u00e9tude de march\u00e9\",\"\u00e9tude de march\u00e9 de la sant\u00e9\",\"\u00e9tude de march\u00e9 pour les m\u00e9decins ricerche di mercato per medici\",\"\u00e9tude de march\u00e9 pour les patients\",\"\u00e9tudes de march\u00e9\",\"\u00e9tudes de march\u00e9 r\u00e9mun\u00e9r\u00e9es\",\"europe and the usa\",\"Globaali influenssapandemia\",\"Global influensapandemi\",\"Global influenza pandemic\",\"Global influenzapandemi\",\"Globale Influenzapandemie\",\"hannah brown\",\"healthcare market research\",\"industria de investigaci\u00f3n de mercado\",\"investigaci\u00f3n de mercado\",\"investigaci\u00f3n de mercado para m\u00e9dicos\",\"investigaci\u00f3n de mercado para pacientes\",\"investigaci\u00f3n de mercado remunerada\",\"investigaci\u00f3n de mercado sanitario\",\"m3 inc\",\"m3 india\",\"maksettu markkinatutkimus\",\"markedsf\u00f8ringsunders\u00f8gelser markkinointitutkimusyritykset\",\"markedsf\u00f8ringsunders\u00f8kelser\",\"markedsunders\u00f8gelse\",\"markedsunders\u00f8gelse inden for sundhedsydelser\",\"markedsunders\u00f8gelser\",\"markedsunders\u00f8gelser for l\u00e6ger\",\"markedsunders\u00f8gelser for patienter\",\"markedsunders\u00f8gelsesindustri\",\"markedsunders\u00f8kelser\",\"markedsunders\u00f8kelser for leger\",\"markedsunders\u00f8kelser for pasienter\",\"markedsunders\u00f8kelser innen helsevesenet\",\"markedsunders\u00f8kelsesindustri\",\"market research\",\"market research for patients\",\"market research for physicians Marktforschung f\u00fcr \u00c4rzte\",\"market research industry\",\"marketing research companies\",\"marketing research surveys\",\"markkinatutkimus\",\"markkinatutkimus l\u00e4\u00e4k\u00e4reille\",\"markkinatutkimus potilaille\",\"markkinatutkimusala\",\"markkinointitutkimukset\",\"marknadsf\u00f6ringsf\u00f6retag\",\"marknadsunders\u00f6kning\",\"marknadsunders\u00f6kningar\",\"marknadsunders\u00f6kningar f\u00f6r l\u00e4kare\",\"marknadsunders\u00f6kningar f\u00f6r patienter\",\"marknadsunders\u00f6kningar inom sjukv\u00e5rden\",\"marknadsunders\u00f6kningsindustri\",\"Marktforschung\",\"Marktforschung f\u00fcr Patienten\",\"Marktforschung im Gesundheitswesen\",\"Marktforschungsbranche\",\"Marktforschungsumfragen\",\"Marktforschungsunternehmen\",\"medigate\",\"neil phillips\",\"paid market research\",\"pandeeminen\",\"pandemi\",\"pandemia\",\"Pandemia influenzale globale\",\"Pandemia mundial de gripe\",\"pandemias\",\"pandemiat\",\"pandemics\",\"pand\u00e9mie\",\"Pand\u00e9mie mondiale de grippe\",\"Pandemie pandemia\",\"Pandemien\",\"pandemier\",\"pand\u00e9mies\",\"Professor Drayson Birmingham\",\"ricerca di mercato\",\"ricerche di mercato a pagamento\",\"ricerche di mercato nel settore sanitario\",\"ricerche di mercato per pazienti\",\"SARS-CoV-2\",\"secteur des \u00e9tudes de march\u00e9\",\"settore delle ricerche di mercato\",\"SI\",\"societ\u00e0 di ricerche di mercato\",\"soci\u00e9t\u00e9s d'\u00e9tudes de march\u00e9\",\"sondaggi di ricerca di mercato\",\"terveydenhuollon markkinatutkimus\",\"threat level\",\"University of Birmingham\"],\"articleSection\":[\"M3 Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/#respond\"]}]},{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/\",\"name\":\"\\\"Covid-19 Testing\\\" in collaboration with the University of Birmingham – M3 Global Research\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/Slide1.jpeg\",\"datePublished\":\"2020-05-04T15:35:33+00:00\",\"description\":\"This research study investigated how 20,996 healthcare professionals, in 29 countries, might use SARS-CoV-2 antigen and antibody tests in COVID-19 cases.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/Slide1.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/Slide1.jpeg\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/covid-19-testing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"“Covid-19 Testing” in collaboration with the University of Birmingham\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\",\"name\":\"M3 Global Research\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\",\"name\":\"M3 Global Research\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":null,\"contentUrl\":null,\"width\":null,\"height\":null,\"caption\":\"M3 Global Research\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/en-gb.facebook.com\\\/M3GlobalResearch\\\/\",\"https:\\\/\\\/x.com\\\/M3GR_Community\",\"https:\\\/\\\/www.instagram.com\\\/m3globalresearch\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/10557915\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/person\\\/11bace963d7a45380011c4911a822a6c\",\"name\":\"m3gr-blog-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g\",\"caption\":\"m3gr-blog-admin\"},\"sameAs\":[\"https:\\\/\\\/blog.m3globalresearch.com\"],\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/author\\\/m3gr-blog-admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\"Covid-19 Testing\" in collaboration with the University of Birmingham – M3 Global Research","description":"This research study investigated how 20,996 healthcare professionals, in 29 countries, might use SARS-CoV-2 antigen and antibody tests in COVID-19 cases.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/","og_locale":"en_US","og_type":"article","og_title":"\"Covid-19 Testing\" in collaboration with the University of Birmingham","og_description":"This research study investigated how 20,996 healthcare professionals, in 29 countries, might use SARS-CoV-2 antigen and antibody tests in COVID-19 cases.","og_url":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/","og_site_name":"M3 Global Research","article_publisher":"https:\/\/en-gb.facebook.com\/M3GlobalResearch\/","article_published_time":"2020-05-04T15:35:33+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/05\/Slide1.jpeg","type":"image\/jpeg"}],"author":"m3gr-blog-admin","twitter_card":"summary_large_image","twitter_creator":"@M3GR_Community","twitter_site":"@M3GR_Community","twitter_misc":{"Written by":"m3gr-blog-admin","Est. reading time":"13 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/#article","isPartOf":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/"},"author":{"name":"m3gr-blog-admin","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/person\/11bace963d7a45380011c4911a822a6c"},"headline":"“Covid-19 Testing” in collaboration with the University of Birmingham","datePublished":"2020-05-04T15:35:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/"},"wordCount":1436,"commentCount":0,"publisher":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/05\/Slide1.jpeg","keywords":["antibody","antigen test","anton richter","betald marknadsunders\u00f6kning","betalt markedsunders\u00f8gelse","betalt markedsunders\u00f8kelse","bezahlte Marktforschung","birmingham","corona threat level","Coronaviridae","coronavirus and sars","coronavirus cause","coronavirus hku1","coronavirus in dogs","coronavirus in europe","coronavirus in us","coronavirus infection","coronavirus symptoms in humans","Coronavirus tracker study","coronavirus update","COVID","COVID-19","COVID-19 and media","covid-19 antibody","covid-19 antigen","COVID-19 news","diagnostic test","Dr. Adrian Shields","Dr.Alex Richter","Dr.Alex Richter Birmingham","Dr.Alex Richter University of Birmingham","ekas","eksen","empresas de investigaci\u00f3n de mercado","encuestas de investigaci\u00f3n de mercado","\u00e9tude de march\u00e9","\u00e9tude de march\u00e9 de la sant\u00e9","\u00e9tude de march\u00e9 pour les m\u00e9decins ricerche di mercato per medici","\u00e9tude de march\u00e9 pour les patients","\u00e9tudes de march\u00e9","\u00e9tudes de march\u00e9 r\u00e9mun\u00e9r\u00e9es","europe and the usa","Globaali influenssapandemia","Global influensapandemi","Global influenza pandemic","Global influenzapandemi","Globale Influenzapandemie","hannah brown","healthcare market research","industria de investigaci\u00f3n de mercado","investigaci\u00f3n de mercado","investigaci\u00f3n de mercado para m\u00e9dicos","investigaci\u00f3n de mercado para pacientes","investigaci\u00f3n de mercado remunerada","investigaci\u00f3n de mercado sanitario","m3 inc","m3 india","maksettu markkinatutkimus","markedsf\u00f8ringsunders\u00f8gelser markkinointitutkimusyritykset","markedsf\u00f8ringsunders\u00f8kelser","markedsunders\u00f8gelse","markedsunders\u00f8gelse inden for sundhedsydelser","markedsunders\u00f8gelser","markedsunders\u00f8gelser for l\u00e6ger","markedsunders\u00f8gelser for patienter","markedsunders\u00f8gelsesindustri","markedsunders\u00f8kelser","markedsunders\u00f8kelser for leger","markedsunders\u00f8kelser for pasienter","markedsunders\u00f8kelser innen helsevesenet","markedsunders\u00f8kelsesindustri","market research","market research for patients","market research for physicians Marktforschung f\u00fcr \u00c4rzte","market research industry","marketing research companies","marketing research surveys","markkinatutkimus","markkinatutkimus l\u00e4\u00e4k\u00e4reille","markkinatutkimus potilaille","markkinatutkimusala","markkinointitutkimukset","marknadsf\u00f6ringsf\u00f6retag","marknadsunders\u00f6kning","marknadsunders\u00f6kningar","marknadsunders\u00f6kningar f\u00f6r l\u00e4kare","marknadsunders\u00f6kningar f\u00f6r patienter","marknadsunders\u00f6kningar inom sjukv\u00e5rden","marknadsunders\u00f6kningsindustri","Marktforschung","Marktforschung f\u00fcr Patienten","Marktforschung im Gesundheitswesen","Marktforschungsbranche","Marktforschungsumfragen","Marktforschungsunternehmen","medigate","neil phillips","paid market research","pandeeminen","pandemi","pandemia","Pandemia influenzale globale","Pandemia mundial de gripe","pandemias","pandemiat","pandemics","pand\u00e9mie","Pand\u00e9mie mondiale de grippe","Pandemie pandemia","Pandemien","pandemier","pand\u00e9mies","Professor Drayson Birmingham","ricerca di mercato","ricerche di mercato a pagamento","ricerche di mercato nel settore sanitario","ricerche di mercato per pazienti","SARS-CoV-2","secteur des \u00e9tudes de march\u00e9","settore delle ricerche di mercato","SI","societ\u00e0 di ricerche di mercato","soci\u00e9t\u00e9s d'\u00e9tudes de march\u00e9","sondaggi di ricerca di mercato","terveydenhuollon markkinatutkimus","threat level","University of Birmingham"],"articleSection":["M3 Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/#respond"]}]},{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/","url":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/","name":"\"Covid-19 Testing\" in collaboration with the University of Birmingham – M3 Global Research","isPartOf":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/#primaryimage"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/05\/Slide1.jpeg","datePublished":"2020-05-04T15:35:33+00:00","description":"This research study investigated how 20,996 healthcare professionals, in 29 countries, might use SARS-CoV-2 antigen and antibody tests in COVID-19 cases.","breadcrumb":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/#primaryimage","url":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/05\/Slide1.jpeg","contentUrl":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/05\/Slide1.jpeg","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.m3globalresearch.com\/blog\/covid-19-testing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.m3globalresearch.com\/blog\/"},{"@type":"ListItem","position":2,"name":"“Covid-19 Testing” in collaboration with the University of Birmingham"}]},{"@type":"WebSite","@id":"https:\/\/www.m3globalresearch.com\/blog\/#website","url":"https:\/\/www.m3globalresearch.com\/blog\/","name":"M3 Global Research","description":"","publisher":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.m3globalresearch.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization","name":"M3 Global Research","url":"https:\/\/www.m3globalresearch.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/logo\/image\/","url":null,"contentUrl":null,"width":null,"height":null,"caption":"M3 Global Research"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/en-gb.facebook.com\/M3GlobalResearch\/","https:\/\/x.com\/M3GR_Community","https:\/\/www.instagram.com\/m3globalresearch","https:\/\/www.linkedin.com\/company\/10557915"]},{"@type":"Person","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/person\/11bace963d7a45380011c4911a822a6c","name":"m3gr-blog-admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g","caption":"m3gr-blog-admin"},"sameAs":["https:\/\/blog.m3globalresearch.com"],"url":"https:\/\/www.m3globalresearch.com\/blog\/author\/m3gr-blog-admin\/"}]}},"jetpack_featured_media_url":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/05\/Slide1.jpeg","jetpack_sharing_enabled":true,"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/9109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/comments?post=9109"}],"version-history":[{"count":0,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/9109\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/media\/9149"}],"wp:attachment":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/media?parent=9109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/categories?post=9109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/tags?post=9109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}